Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Staropoli

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Nature Communications|November 21, 2025
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivoSimon Blachier, Marie-Christine Vaney, Laurine Conquet, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionDelphine Planas, Isabelle Staropoli, Vincent Michel, et al.
Cell Reports. Medicine|November 30, 2022
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesTimothée Bruel, Karl Stéfic, Yann Nguyen, et al.
Nature Communications|January 27, 2022
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entryMathieu Claireaux, Rémy Robinot, Jérôme Kervevan, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
Nature Communications|March 14, 2024
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionDelphine Planas, Isabelle Staropoli, Vincent Michel, et al.
Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.
Iscience|July 29, 2024
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, et al.
Nature Medicine|March 24, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesTimothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 16, 2021
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020Arnaud Fontanet, Laura Tondeur, Rebecca Grant, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Nature Communications|November 21, 2025
Targeting ACE2 with a camelid antibody inhibits SARS-CoV-2 binding and has protective effects in vivoSimon Blachier, Marie-Christine Vaney, Laurine Conquet, et al.
Biorxiv : the Preprint Server for Biology|December 4, 2023
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionDelphine Planas, Isabelle Staropoli, Vincent Michel, et al.
Cell Reports. Medicine|November 30, 2022
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodiesTimothée Bruel, Karl Stéfic, Yann Nguyen, et al.
Nature Communications|January 27, 2022
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entryMathieu Claireaux, Rémy Robinot, Jérôme Kervevan, et al.
Ebiomedicine|March 15, 2022
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2Nell Saunders, Delphine Planas, William H Bolland, et al.
Nature Communications|March 14, 2024
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasionDelphine Planas, Isabelle Staropoli, Vincent Michel, et al.
Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.
Iscience|July 29, 2024
Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2Cyril Planchais, Ignacio Fernández, Benjamin Chalopin, et al.
Nature Medicine|March 24, 2022
Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodiesTimothée Bruel, Jérôme Hadjadj, Piet Maes, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 16, 2021
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020Arnaud Fontanet, Laura Tondeur, Rebecca Grant, et al.
Pageof 7